Non-nucleosides are a powerful option for treating HIV, but cross-resistance can mean you only get one bite of the cherry. This is the final instalment in a three-part series looking at key drug classes.
From the July 2006 issue of Positive Living
Non-nucleosides are a powerful option for treating HIV, but cross-resistance can mean you only get one bite of the cherry. This is the final instalment in a three-part series looking at key drug classes.